ALX Oncology Holdings Inc.

NasdaqGS:ALXO Stock Report

Market Cap: US$79.6m

ALX Oncology Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ALXO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Aug 24SellUS$1,455Shelly PintoIndividual564US$2.58
14 Aug 24SellUS$4,997Jaume PonsIndividual1,937US$2.58
14 Aug 24SellUS$3,522Sophia RandolphIndividual1,365US$2.58
05 Jul 24SellUS$10,025Shelly PintoIndividual1,823US$5.50
01 Jul 24SellUS$62,599Jaume PonsIndividual10,758US$5.82
01 Jul 24SellUS$19,045Sophia RandolphIndividual3,273US$5.82
01 Jul 24SellUS$7,989Shelly PintoIndividual1,373US$5.82
13 Jun 24BuyUS$102,338Peter GarciaIndividual12,000US$8.53
14 Mar 24BuyUS$49,771Jason LettmannIndividual4,400US$11.31
12 Feb 24SellUS$17,896,851LSV Capital Management, LLCCompany1,259,395US$15.59
04 Jan 24SellUS$36,957Shelly PintoIndividual2,717US$13.60
29 Dec 23SellUS$24,530Shelly PintoIndividual1,631US$15.04
29 Dec 23SellUS$107,972Jaume PonsIndividual7,179US$15.04
29 Dec 23SellUS$28,471Peter GarciaIndividual1,893US$15.04
29 Dec 23SellUS$47,045Sophia RandolphIndividual3,128US$15.04
13 Dec 23SellUS$4,101,290LSV Capital Management, LLCCompany317,988US$13.19

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ALXO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,100,0852.09%
General Public1,394,4192.64%
Hedge Funds3,836,5767.27%
VC/PE Firms16,684,02731.6%
Institutions29,727,99756.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.9%.

Top Shareholders

Top 25 shareholders own 89.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.4%
venBio LLC
9,699,925US$14.6m0%7.13%
11.1%
FMR LLC
5,865,106US$8.9m-25%no data
7.97%
Tang Capital Management, LLC
4,204,735US$6.3m0%0.45%
7.65%
Vivo Capital, LLC
4,034,522US$6.1m-4.4%0.47%
7.27%
Redmile Group, LLC
3,836,576US$5.8m-4.95%0.29%
5.59%
LSV Capital Management, LLC
2,949,580US$4.5m0%100.0%
4.93%
BlackRock, Inc.
2,601,776US$3.9m-3.19%no data
4.57%
BioImpact Capital LLC
2,409,862US$3.6m10.5%0.55%
3.8%
Millennium Management LLC
2,002,374US$3.0m51.1%no data
3.57%
The Vanguard Group, Inc.
1,884,573US$2.8m9.11%no data
2.84%
HBM Partners Ltd.
1,500,000US$2.3m0%0.23%
1.33%
Geode Capital Management, LLC
700,847US$1.1m0.06%no data
1.27%
State Street Global Advisors, Inc.
671,376US$1.0m-4.84%no data
1.25%
Two Sigma Investments, LP
660,059US$996.7k126%no data
0.97%
Privium Fund Management BV
509,059US$768.7k28.2%0.12%
0.95%
Two Sigma Advisers, LP
500,500US$755.8k640%no data
0.88%
Jaume Pons
461,510US$696.9k2.54%no data
0.87%
Qube Research & Technologies Ltd
457,717US$691.2k80,100%no data
0.81%
Acadian Asset Management LLC
426,424US$643.9k0%no data
0.75%
Point72 Asset Management, L.P.
396,480US$598.7k-21.6%no data
0.61%
Northern Trust Global Investments
319,742US$482.8k30.8%no data
0.6%
XTX Holdings Limited, Asset Management Arm
317,322US$479.2k0%0.03%
0.55%
D. E. Shaw & Co., L.P.
290,396US$438.5k1,430%no data
0.49%
Los Angeles Capital Management LLC
257,779US$389.2k160%no data
0.48%
Sophia Randolph
255,461US$385.7k3.23%no data